These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 20071147)
1. DSM-IV catatonia signs and criteria in first-episode, drug-naive, psychotic patients: psychometric validity and response to antipsychotic medication. Peralta V; Campos MS; de Jalon EG; Cuesta MJ Schizophr Res; 2010 May; 118(1-3):168-75. PubMed ID: 20071147 [TBL] [Abstract][Full Text] [Related]
2. Covariation between motor signs and negative symptoms in drug-naive subjects with schizophrenia-spectrum disorders before and after antipsychotic treatment. Peralta V; de Jalón EG; Campos MS; Cuesta MJ Schizophr Res; 2018 Oct; 200():85-91. PubMed ID: 28864283 [TBL] [Abstract][Full Text] [Related]
3. [Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics]. Belaizi M; Yahia A; Mehssani J; Bouchikhi Idrissi ML; Bichra MZ Encephale; 2013 Jun; 39(3):224-31. PubMed ID: 23095594 [TBL] [Abstract][Full Text] [Related]
4. Characterization of affective domains within the nonaffective psychotic disorders. Peralta V; Cuesta MJ Schizophr Res; 2009 Jun; 111(1-3):61-9. PubMed ID: 19321311 [TBL] [Abstract][Full Text] [Related]
5. The diagnostic criteria and structure of catatonia. Wilson JE; Niu K; Nicolson SE; Levine SZ; Heckers S Schizophr Res; 2015 May; 164(1-3):256-62. PubMed ID: 25595653 [TBL] [Abstract][Full Text] [Related]
6. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196 [TBL] [Abstract][Full Text] [Related]
7. The validity of the DSM-IV diagnostic classification system of non-affective psychoses. Korver-Nieberg N; Quee PJ; Boos HB; Simons CJ; Aust N Z J Psychiatry; 2011 Dec; 45(12):1061-8. PubMed ID: 22026404 [TBL] [Abstract][Full Text] [Related]
8. Motor behavior abnormalities in drug-naïve patients with schizophrenia spectrum disorders. Peralta V; Campos MS; De Jalón EG; Cuesta MJ Mov Disord; 2010 Jun; 25(8):1068-76. PubMed ID: 20222137 [TBL] [Abstract][Full Text] [Related]
9. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. Crespo-Facorro B; Pérez-Iglesias R; Mata I; Caseiro O; Martínez-Garcia O; Pardo G; Ramirez-Bonilla M; Pelayo-Terán JM; Vázquez-Barquero JL J Psychiatr Res; 2011 Jun; 45(6):763-9. PubMed ID: 21106207 [TBL] [Abstract][Full Text] [Related]
10. [The schizophrenia spectrum and other psychotic disorders in the DSM-5]. Tan N; van Os J Tijdschr Psychiatr; 2014; 56(3):167-72. PubMed ID: 24643825 [TBL] [Abstract][Full Text] [Related]
11. Psychotic disorders in DSM-5: summary of changes. Carpenter WT; Tandon R Asian J Psychiatr; 2013 Jun; 6(3):266-8. PubMed ID: 23642992 [TBL] [Abstract][Full Text] [Related]
12. [Minor neurological and physical anomalies in patients with first-episode psychosis]. Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597 [TBL] [Abstract][Full Text] [Related]
13. Schizophrenia and other psychotic disorders in DSM-5. Tandon R Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):16-9. PubMed ID: 23538289 [TBL] [Abstract][Full Text] [Related]
14. Spurious precision: procedural validity of diagnostic assessment in psychotic disorders. McGorry PD; Mihalopoulos C; Henry L; Dakis J; Jackson HJ; Flaum M; Harrigan S; McKenzie D; Kulkarni J; Karoly R Am J Psychiatry; 1995 Feb; 152(2):220-3. PubMed ID: 7840355 [TBL] [Abstract][Full Text] [Related]
15. Catatonia in DSM-5. Tandon R; Heckers S; Bustillo J; Barch DM; Gaebel W; Gur RE; Malaspina D; Owen MJ; Schultz S; Tsuang M; van Os J; Carpenter W Schizophr Res; 2013 Oct; 150(1):26-30. PubMed ID: 23806583 [TBL] [Abstract][Full Text] [Related]
16. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G; Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797 [TBL] [Abstract][Full Text] [Related]
17. Predicting diagnostic change among patients diagnosed with first-episode DSM-IV-TR major depressive disorder with psychotic features. Salvatore P; Baldessarini RJ; Khalsa HM; Amore M; Di Vittorio C; Ferraro G; Maggini C; Tohen M J Clin Psychiatry; 2013 Jul; 74(7):723-31; quiz 731. PubMed ID: 23945450 [TBL] [Abstract][Full Text] [Related]
18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study. Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992 [TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Honer WG; Kopala LC; Rabinowitz J J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]